Hält derzeit Positionen bei Seres Therapeutics Inc, Genzyme Corp and Cubist Pharmaceuticals LLC
Position | Company | Period |
---|---|---|
Chief Legal Officer, Executive Vice President and Secretary | Seres Therapeutics Inc | 1. Mai 2016 - |
Chief Legal Officer, Senior Vice President, General Counsel | Genzyme Corp | 22. Mai 2008 - |
Executive Vice President, Chief Legal and Administrative Officer and Secretary | Cubist Pharmaceuticals LLC | 1. Februar 2014 - |
Executive Vice President, Chief Legal and Administrative Officer, Secretary | ARIAD Pharmaceuticals Inc | 1. Januar 2015 - 30. April 2016 |
Senior Vice President, General Counsel, Secretary | Cubist Pharmaceuticals LLC | 1. März 2013 - 1. Februar 2014 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-10-31 | 2023-10-30 |
Seres Therapeutics Inc
(MCRB)
|
GV Geplanter Verkauf |
4.156
-3.5%
1,355.611 USD |
4.156 -3.5% | 1,35 | 5.611 USD | |
2019-01-29 | 2019-01-28 |
Seres Therapeutics Inc
(MCRB)
|
V Verkauf |
5.471
-25.4%
5,7531.478 USD |
5.471 -25.4% | 5,75 | 31.478 USD |